logo
A.D.A.M. Consumer Health Successfully Maintains URAC Certification; Reinforces Commitment to Quality and Excellence

A.D.A.M. Consumer Health Successfully Maintains URAC Certification; Reinforces Commitment to Quality and Excellence

JOHNS CREEK, Ga., Aug. 13, 2025 /PRNewswire/ -- A.D.A.M. Consumer Health (A.D.A.M.), part of the global Ebix Group, has successfully passed and maintained its URAC Health Content Provider Certification — a significant milestone underscoring the company's commitment to providing credible, high-quality, and trusted health information to consumers.
A.D.A.M was one of the first organizations to receive URAC Health Website Accreditation in 2001. Maintaining URAC certification for the past 24 consecutive years ensures that A.D.A.M. Consumer Health products are aligned with benchmarks of transparency, editorial integrity, and patient empowerment.
A.D.A.M. has shown continued leadership in health education solutions, medical illustrations, and evidence-based content development. With a client base that includes hospitals, healthcare providers, educational institutions, insurance organizations, and other digital platforms globally, A.D.A.M. remains a cornerstone in the Ebix Group's healthcare content and eLearning vertical.
Commenting on this achievement, Ashish Jaitly ED & CEO, Global Technology Business, stated:
'Maintaining the URAC Certification in such a dynamic operational environment is an achievement and we are truly proud of it. This reaffirms the trust placed in A.D.A.M. by our global customers and strengthens our ability to offer high-integrity content that educates and empowers users.'
A.D.A.M. continues to strengthen their footprint in health and wellness, this certification reinforces A.D.A.M.'s position as a trusted global content leader, advancing healthcare literacy and digital enablement at scale.
About URAC Health Content Provider Certification:
URAC's Health Content Provider Certification, administered by the Washington D.C.-based independent accreditation organization is a prestigious U.S.-based accreditation globally respected for its rigorous standards in consumer-facing health content. It serves as a gold standard for verifying that published health information is evidence-based, medically accurate, current, and developed under strict editorial oversight by qualified healthcare professionals. The certification process includes a comprehensive evaluation of content development protocols, editorial policies, update frequency, and quality assurance mechanisms—ensuring alignment with evolving healthcare standards and safeguarding against misinformation in today's digital landscape. While grounded in U.S. healthcare practices, URAC's accreditation is valued internationally as a benchmark of credibility, integrity, and trust. For organizations like A.D.A.M. Consumer Health, maintaining this certification reflects a deep commitment to public health education, editorial excellence, and the delivery of reliable, transparent medical content that empowers informed healthcare decisions. https://accreditnet.urac.org/directory/#/certification/HCP010004/info
About A.D.A.M.
A.D.A.M. is headquartered in Johns Creek, Georgia. A.D.A.M. is a business unit of Ebix Inc. and for over two decades, has been a leading developer of interactive health and medical information for websites, consumer health portals, healthcare, insurance, biomedical, medical device, pharmaceutical and academic organizations. A.D.A.M.'s products combine physician-reviewed text, medical illustrations, multimedia, and interactive tools and technology that explain complex medical and health information in a consumer-friendly manner. For more information, visit www.adam.com
CONTACT:
[email protected]
View original content to download multimedia: https://www.prnewswire.com/news-releases/adam-consumer-health-successfully-maintains-urac-certification-reinforces-commitment-to-quality-and-excellence-302529188.html
SOURCE EBIX INC
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Blood Oxygen Tracking Returns to U.S. Apple Watches Today After 5-Year Patent Dispute
Blood Oxygen Tracking Returns to U.S. Apple Watches Today After 5-Year Patent Dispute

Gizmodo

time3 minutes ago

  • Gizmodo

Blood Oxygen Tracking Returns to U.S. Apple Watches Today After 5-Year Patent Dispute

Good news: Apple Watches sold in the U.S. after January 2024 lost their built-in blood oxygen tracking because of a patent dispute with medical company Masimo, but the feature will return via a software update coming out today. In a Newsroom post, Apple says it's introducing a 'redesigned Blood Oxygen feature for some Apple Watch Series 9, Series 10, and Apple Watch Ultra 2.' The reworked blood oxygen feature will be pushed out on iPhone and Apple Watch via an iOS 18.6.1 and watchOS 11.6.1 software update. 'Following this update, sensor data from the Blood Oxygen app on Apple Watch will be measured and calculated on the paired iPhone, and results can be viewed in the Respiratory section of the Health app.' Apple also added, 'There will be no impact to Apple Watch units previously purchased that include the original Blood Oxygen feature, nor to Apple Watch units purchased outside of the U.S.' Neither Apple nor Masimo has shared full details on how blood oxygen tracking is returning to impacted Apple Watches. 'This update was enabled by a recent U.S. Customs ruling,' writes the iPhone maker. Blood oxygen tracking was disabled on Apple Watch Series 9, Series 10, and Apple Watch Ultra 2 after Masimo sued Apple in 2020 for infringing on its health monitoring patents. At the center of the lawsuit was how the Apple Watch measured pulse oximetry via noninvasive sensors, which led to Apple disabling blood oxygen monitoring in smartwatches shipped to the U.S. The hardware sensors were still present on all shipping Apple Watches; the feature was only disabled in software, leaving open the possibility for some future resolution. Five years after being sued and 1.5 years after shipping disabled Apple Watches to the U.S., blood oxygen is returning. The timing couldn't be better for the tech giant. The company is less than a month out from announcing new Apple Watches—likely Series 11 and possibly Ultra 3—alongside a family of iPhone 17 devices and maybe even new AirPods with a live translation feature. Somewhere at Apple Park, Tim Cook and COO Jeff Williams, who led Apple Watch design but is leaving by the end of the year, are cracking open some tall boys in celebration. This story is developing…

Decoding The Molecular Benefits Of Exercise
Decoding The Molecular Benefits Of Exercise

Forbes

time4 minutes ago

  • Forbes

Decoding The Molecular Benefits Of Exercise

There has always been a dream that there could be a pill to replace exercise. New research suggests a molecule called betaine, naturally produced by the kidneys, may do just that. According to a new study published in Cell, it may mimic many of the health-protective effects of exercise. This suggests that it could help protect against aging-related decline, even in individuals who are unable to maintain regular physical activity. Betaine is produced by the kidneys. Previous research has linked it to cardiovascular health and liver function, but its role in geroprotection has been underappreciated. This research shows the kidney acts as a command center in exercise-driven rejuvenation. Betaine directly inhibits key drivers of inflammation, silencing 'inflammaging'—chronic inflammation that accelerates cellular aging. This links movement at the gym to age-defying changes in cellular Molecular Language of Movement Decades of research have linked regular exercise to longer lifespans and reduced risk for inflammation-driven diseases. Therefore, we know exercise is beneficial, but the mechanisms—what actually changes at the microscopic level—are not well understood. For example, activities such as running, cycling or resistance training have a positive effect on metabolism and heart health. Recent advances now enable us to investigate the molecular changes underlying these improvements. This new study presents a systematic, cell-by-cell analysis. It looks at how both acute and sustained exercise drive rapid shifts in molecular signatures, redefining our understanding of 'exercise as medicine'. The study tracked 13 healthy human volunteers over periods of rest, a single 5-km run, and long-term training in the form of 25 days of running. During these periods, samples were collected. These examined how the body's cells and molecules responded. More specifically, the study went beyond general health markers. It used advanced techniques, such as single-cell sequencing, to determine which genes are activated in individual cells during exercise. It also measures proteins, small molecules related to metabolism and it studies the gut microbiome. To explain this in simpler terms, you might compare this to a car tune-up. Even short, regular sessions of exercise prompt the body to 'fix' and 'upgrade' its cellular machinery, leading to wide-ranging health improvements. The study's use of sophisticated technology is like opening the hood and not just checking the oil, but inspecting every engine part for improvement. These tests and samples provide an unprecedented, detailed insight into the body's inner workings in response to exercise. The findings show that a single workout triggers a short burst of inflammation, described as 'metabolic chaos,' that helps the body adjust to sudden physical stress. Sustained exercise, on the other hand, reprograms the body towards youthfulness, reshapes the gut microbiome, enhances antioxidant activity, promotes DNA stability in immune cells and elevates betaine Path Forward in Understanding the Molecular Benefits of Exercise These results build upon prior work linking exercise to reductions in cellular senescence, tissue inflammation, and metabolic disease—all key hallmarks of aging. What distinguishes this research is the identification of a single, kidney-derived metabolite that can orchestrate what is known as systemic geroprotection. Consider the case of elderly patients facing joint pain or disability. They are often unable to engage in adequate physical activity. Betaine supplementation, pending further clinical validation, could potentially offer a pharmacological lifeline to healthspan extension, helping these individuals maintain independence and quality of life without the barrier of vigorous exercise. That said, the study tested only a small, similar group of people, so we can't be sure the results apply to everyone. The limited sample size and lack of participant diversity mean that the findings may not be generalizable to broader populations. Still, the early results are promising. As research moves from bench to bedside, we approach an era where the secrets of exercise may be unlocked—and replicated—to benefit all.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store